Disclosure 0001950232-26-000003-1

SEC FORM 4

$17,771.80

LIGAND PHARMACEUTICALS INC (LGND)

Acquisition (code M) of 340 shares at $52.27 per share.

Reporting Person Reardon Andrew · Officer Title CLO & Secretary · Transaction Code M

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001950232-26-000003 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "LIGAND PHARMACEUTICALS INC (LGND)." Disclosed 2026-10-06. https://desqlong.com/cards/0001950232-26-000003-1 (retrieved 2026-10-07).